BioPhorum introduces – the Speed to Clinic initiative
Broadcast date
Thu, Oct 20, 2022
Presented by
- Richard Alldread - CSL BehringKartik Subramanian - AbbvieNick Abu-Absi - Abbvie
Quick Description
Spurred on by lessons learned from the COVID-19 pandemic, combined with the ever-pressing need to streamline development and get medicines to clinics faster, BioPhorum has launched a Speed to Clinic initiative. As a priority topic for the industry, this has been met with much enthusiasm.
Details
Spurred on by lessons learned from the COVID-19 pandemic, combined with the ever-pressing need to streamline development and get medicines to clinics faster, BioPhorum has launched a Speed to Clinic initiative. As a priority topic for the industry, this has been met with much enthusiasm. We hear from Richard Alldread, Senior Director, Recombinant Product Development at CSL Behring Innovation GmbH, and Kartik Subramanian, Vice President, Science & Technology Biologics and Nick Abu-Absi, Director, Cell Culture Development both at AbbVie. They share their thoughts about the importance of this initiative, and outline how the industry is working together to solve the challenges of bringing medicines to clinic more quickly and effectively.
Speakers
Richard Alldread
Senior Director, Recombinant Product Development
CSL Behring
Kartik Subramanian
Vice President, Science & Technology Biologics
Abbvie
Nick Abu-Absi
Director, Cell Culture Development
Abbvie